Phyllis Bryant Mobley
Psychiatry · Columbia, SCNPI 1902891294
Payments from drug & device makers
Across 205 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$705
- Alkermes, Inc.$345
- Otsuka America Pharmaceutical, Inc.$301
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$183
- AbbVie$142
- plus $516 from 10 others
What the payments were for
- Food & beverage$3,377100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,377 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $123,150 |
| Invega SustennaPaliperidone Palmitate | 28 | $92,715 |
| Abilify MaintenaAripiprazole | 21 | $52,050 |
| AristadaAripiprazole Lauroxil | 12 | $38,269 |
| Risperdal ConstaRisperidone Microspheres | 13 | $33,002 |
| Haloperidol Decanoate | 57 | $4,370 |
| Clozapine | 34 | $3,005 |
| Risperidone | 89 | $2,780 |
| Aripiprazole | 28 | $1,725 |
| Bupropion XlBupropion Hcl | 53 | $1,694 |
| Haloperidol | 30 | $1,279 |
| Benztropine Mesylate | 65 | $1,187 |
| Prazosin Hcl | 33 | $988 |
| Lorazepam | 74 | $970 |
| Divalproex Sodium ErDivalproex Sodium | 25 | $862 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $79 | $125,71741 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,184 | $123,15016 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $301 | $52,05021 claims |
| Alkermes, Inc.Aristada | $345 | $38,26912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Columbia
- Meera NarasimhanColumbia$146K
- Gariane GunterColumbia$46K
- Deborah LeveretteColumbia$11K
- Nioaka CampbellColumbia$11K
- Timothy MaloneColumbia$7K
- Kelly DionColumbia$7K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.